Tonix Pharmaceuticals Holding Stock Price Prediction

TNXP Stock  USD 0.19  0.01  5.00%   
As of today, the RSI of Tonix Pharmaceuticals' share price is approaching 39. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Tonix Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

39

 
Oversold
 
Overbought
The successful prediction of Tonix Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Tonix Pharmaceuticals Holding, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Tonix Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(2.97)
EPS Estimate Current Year
(35.52)
EPS Estimate Next Year
(27.84)
Wall Street Target Price
21
EPS Estimate Current Quarter
(2.93)
Using Tonix Pharmaceuticals hype-based prediction, you can estimate the value of Tonix Pharmaceuticals Holding from the perspective of Tonix Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Tonix Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Tonix because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Tonix Pharmaceuticals after-hype prediction price

    
  USD 0.2  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Tonix Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tonix Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.122.3010.70
Details
Naive
Forecast
LowNextHigh
00.238.63
Details
2 Analysts
Consensus
LowTargetHigh
7.898.679.62
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-8.88-8.88-8.88
Details

Tonix Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Tonix Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Tonix Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Tonix Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Tonix Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Tonix Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Tonix Pharmaceuticals' historical news coverage. Tonix Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.01 and 8.60, respectively. We have considered Tonix Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.19
0.20
After-hype Price
8.60
Upside
Tonix Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of Tonix Pharmaceuticals is based on 3 months time horizon.

Tonix Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Tonix Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Tonix Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Tonix Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.64 
8.40
  0.01 
  0.11 
12 Events / Month
11 Events / Month
In about 12 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.19
0.20
5.26 
84,000  
Notes

Tonix Pharmaceuticals Hype Timeline

Tonix Pharmaceuticals is at this time traded for 0.19. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.11. Tonix is anticipated to increase in value after the next headline, with the price projected to jump to 0.2 or above. The average volatility of media hype impact on the company the price is over 100%. The price gain on the next news is projected to be 5.26%, whereas the daily expected return is at this time at -0.64%. The volatility of related hype on Tonix Pharmaceuticals is about 5101.21%, with the expected price after the next announcement by competition of 0.08. Tonix Pharmaceuticals Holding currently holds about 145.48 M in cash with (102 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.38, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next anticipated press release will be in about 12 days.
Check out Tonix Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Tonix Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Tonix Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Tonix Pharmaceuticals' future price movements. Getting to know how Tonix Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Tonix Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SONNSonnet Biotherapeutics Holdings 1.15 7 per month 0.00 (0.12) 12.31 (9.79) 37.58 
ONTXOnconova Therapeutics 0.00 0 per month 4.35  0.08  7.69 (8.33) 66.73 
PALIPalisade Bio 0.03 7 per month 0.00 (0.12) 5.97 (8.55) 24.25 
IBIOIbio Inc(0.03)3 per month 3.57  0.08  7.76 (6.47) 30.48 
JAGXJaguar Animal Health(0.01)8 per month 0.00 (0.06) 8.13 (7.94) 27.65 
ACSTAcasti Pharma(0.19)4 per month 2.83  0.05  9.42 (3.85) 25.09 
DFFNDiffusion Pharmaceuticals 0.1 5 per month 0.00 (0.21) 4.09 (5.32) 12.34 
VXRTVaxart Inc 0.02 10 per month 0.00 (0.19) 4.88 (7.37) 20.06 
VBIVVBI Vaccines(0.01)8 per month 0.00 (0.11) 5.63 (33.09) 163.49 
DRUGBright Minds Biosciences(2.81)8 per month 4.51  0.14  34.65 (11.87) 1,471 
VRAXVirax Biolabs Group 0.02 4 per month 0.00 (0.13) 9.65 (12.97) 61.28 
NVAXNovavax(0.67)9 per month 0.00 (0.09) 9.47 (7.08) 38.60 
INOInovio Pharmaceuticals(0.15)8 per month 0.00 (0.29) 3.22 (7.07) 17.45 
ENVBEnveric Biosciences 0.01 6 per month 0.00 (0.16) 6.25 (7.50) 28.33 
CWBRCohBar Inc 0.07 3 per month 5.34  0.08  5.73 (5.59) 250.97 

Tonix Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Tonix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Tonix using various technical indicators. When you analyze Tonix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Tonix Pharmaceuticals Predictive Indicators

The successful prediction of Tonix Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Tonix Pharmaceuticals Holding, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Tonix Pharmaceuticals based on analysis of Tonix Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Tonix Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Tonix Pharmaceuticals's related companies.
 2010 2023 2024 (projected)
Dividend Yield0.0070630.420.44
Price To Sales Ratio0.880.80.7

Story Coverage note for Tonix Pharmaceuticals

The number of cover stories for Tonix Pharmaceuticals depends on current market conditions and Tonix Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Tonix Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Tonix Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Tonix Pharmaceuticals Short Properties

Tonix Pharmaceuticals' future price predictability will typically decrease when Tonix Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Tonix Pharmaceuticals Holding often depends not only on the future outlook of the potential Tonix Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tonix Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding532.5 K
Cash And Short Term Investments24.9 M

Additional Tools for Tonix Stock Analysis

When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.